Resmed Inc DRC (RMD)

Currency in AUD
31.250
+0.140(+0.45%)
Closed·
RMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
30.94031.285
52 wk Range
25.50045.250
Key Statistics
Bid/Ask
31.10 / 31.28
Prev. Close
31.25
Open
31.2
Day's Range
30.94-31.285
52 wk Range
25.5-45.25
Volume
2.89M
Average Volume (3m)
2.04M
1-Year Change
-29.1544%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
39.667
Upside
+26.94%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 14 consecutive years

Resmed Inc DRC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

11 Buy
2 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 39.667
(+26.94% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
CLSA
Buy34.00+8.80%37.00Maintain10-08-2026
Macquarie
Buy46.80+49.76%46.60Maintain10-08-2026
JPMorgan
Buy36.50+16.80%35.80Maintain08-08-2026
JPMorgan
Buy35.80+14.56%37.10Maintain21-07-2026
Canaccord
Buy40.00+28.00%44.50Maintain21-07-2026

Earnings

Latest Release
06-08-2026
EPS / Forecast
2.64 / --
Revenue / Forecast
1.46B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 10.43%
Dividend Yield
1.13%
Industry Median 1.29%
Annualised payout
0.35
Paid unevenly
5-Years Growth
+8.58%
Growth Streak

RMD Income Statement

Compare RMD to Peers and Sector

Metrics to compare
RMD
Peers
Sector
Relationship
P/E Ratio
20.8x17.0x−0.3x
PEG Ratio
2.160.310.00
Price/Book
4.8x2.0x2.6x
Price / LTM Sales
5.6x1.8x3.1x
Upside (Analyst Target)
27.6%−0.8%50.4%
Fair Value Upside
Unlock25.4%6.4%Unlock

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Employees
11370
Market
Australia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
65.36M45.31%2.07B
Other Institutional Investors
54.21M37.58%1.71B
Public Companies & Retail Investors
24.68M17.11%780.48M
Total
144.25M100.00%4.56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Australian Super Pty Ltd10.09%1,45,47,9314,60,151
BlackRock, Inc.8.67%1,25,09,5283,95,676

FAQ

What Is the Resmed DRC (RMD) Share Price Today?

The Resmed DRC share price today is 31.250.

What is the current Resmed DRC (RMD) share price and day range?

As of 19-08-2026, the Resmed DRC share price is 31.250, with a previous close of 31.250. The share price has ranged from 30.940 to 31.285 today, while the 52-week range spans from 25.500 to 45.250.

What Is the Resmed DRC Market Cap?

As of today, Resmed DRC market cap is 46.550B.

What Is the Resmed DRC (RMD) Share Price Target?

The average 12-month share price target for Resmed DRC is 39.667, with a high estimate of 46.75106082 and a low estimate of 32.96605375. 11 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +26.94% Upside potential.

What Is Resmed DRC's Earnings Per Share (TTM)?

The Resmed DRC EPS (TTM) is 10.430.

From a Technical Analysis Perspective, Is RMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Resmed DRC Trade On?

Resmed DRC is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Resmed DRC?

The stock symbol for Resmed DRC is "RMD."

How Many Times Has Resmed DRC Stock Split?

Resmed DRC has split 3 times.

How Many Employees Does Resmed DRC Have?

Resmed DRC has 11370 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.